Pediatria Polska

Abstract

2/2026 vol. 101
Review paper

Long COVID-19 in children: a review of key information

  1. Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland

Pediatr Pol 2026; 101 (2): 161-167

Online publish date: 2026/06/30
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Long COVID in children is defined as a syndrome of persistent symptoms following SARS-CoV-2 infection, which appear within three months after the acute phase, last for at least two months, and have a significant impact on the child’s daily functioning. The symptoms are heterogeneous and may involve multiple organ systems. The causes and risk factors for developing long COVID in the paediatric population remain incompletely understood, and diagnosis may be challenging due to the nonspecific nature of symptoms and the need for thorough differential diagnosis. Further long-term studies are required to establish the true association between acute SARS-CoV-2 infection and the development of long COVID in children. This paper presents fundamental information on long COVID in the paediatric population, with a focus on key risk factors, pathophysiology, clinical manifestations, diagnostic approaches, the importance of vaccination, and the potential role of viral variants in the pathogenesis of long COVID.

Share
without publication fees
without publication fees